Navigation Links
Sunlamps Used to Lowered Blood Pressure in Highly Publicized Dermatology Study
Date:5/16/2013

y year as a surrogate for sun exposure in Canada's light-deprived environment. JCTA members promote sunburn prevention and full education about the effects of UV exposure as a responsible approach. Please Tan Responsibly

About the Joint Canadian Tanning Association:

The Joint Canadian Tanning Association (JCTA) is a national non-profit organization created to increase understanding of the professional tanning industry's scientifically supported position that regular moderate ultra-violet exposure from sunshine or sunbed in a non-burning fashion is part of a responsible lifestyle that recognizes both the inherent benefits and the manageable risks associated with ultraviolet light exposure.

Read the full story at http://www.prweb.com/releases/sunbeds/sunlamps/prweb10739494.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. MAK value lowered for chlorinated biphenyls
2. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
3. For Hospitals, Lowered Death Rates May Not Mean More Readmissions
4. Vicente Fernandez Tickets: Cheap Concert Tickets has Lowered Their Pricing on Vicente Fernandez Tickets at Gibson Amphitheatre Universal City Walk - April 26 - 28, 2013
5. Kinky Boots Tickets: Cheap Concert Tickets Lowered Ticket Prices on all Upcoming Show Dates for Kinky Boots at the Al Hirschfeld Theatre
6. Infection Might Raise Blood Clot Risk for Older Adults: Study
7. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
8. Common Blood Pressure Drug Safe for Heart Failure: Study
9. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
10. High Blood Pressure May Be Especially Lethal for Blacks
11. Changes in gene expression may help explain high blood pressure in pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... its popular VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection ... VitaSkin™ pillars: Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Dr. Trace ... at JourneyLite of Cincinnati. In the last month the FDA has approved two ... Duo ™. These procedures represent the first incisionless, reversible, weight loss procedures available ...
(Date:9/1/2015)... , ... September 01, 2015 ... ... PRO Archiver for Alfresco, a next-generation customer communications archiving solution integrated with ... market-leading technology from Crawford and helps organizations save millions of dollars in ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... interviewed dating men and pick-up artists about their experiences of female beauty, women’s ... bodily concerns, including penis issues, as well as their relationships with other men, ...
(Date:9/1/2015)... ... , ... Anthony J. Tantillo, Esq., Attorney from William Mattar Law Offices, ... in a row. Through nomination, research and strategic evaluation processes, Tantillo continues to ... New York, Tantillo is a Buffalo State College graduate of 1998. Tantillo went ...
Breaking Medicine News(10 mins):Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3Health News:Female Porn Director Explains Male Insecurities about Women in a New Book 2
... SOPHIA ANTIPOLIS, France, May 6 NicOx S.A.,(Euronext ... U.S. phase 2 study,conducted by its partner Pfizer ... doses of PF-03187207 to Xalatan(R) (latanoprost) 0.005% in,patients ... doses of PF-03187207 demonstrated a clinically significant reduction,in ...
... 1st May 2008: Some of the UKs leading experts ... as RFID in hospitals are already improving the efficiency ... that compatibility problems between hardware and software applications, and ... mean that the NHS is not benefiting as much ...
... Researchers have discovered how a mole develops into melanoma ... in 60-70 percent of tumors. The Penn State ... is necessary for drugs to effectively treat this deadly ... two proteins (V600E)B-Raf and Akt3 communicate with ...
... N.Y., May 6 VirtualCDO acted as the ... of the company to Lawson,Software (St. Paul, MN). ... services, assisted healthcare, hospitality and government,service companies in ... enterprise management services to some 4,000 customers across,40 ...
... - DRAXIS Health Inc. (TSX: DAX),(Nasdaq: DRAX ) ... 2008 on Friday May 9, 2008., Annual and ... meeting (the "Meeting") of shareholders of,DRAXIS is scheduled to ... 5300, TD Bank Tower, Toronto, Ontario, Canada on Friday, ...
... Patients, Safety,Concerns, But Lack Confidence About Best Ways ... As patient safety,incidents in America,s hospitals continue ... hospital CEOs feel strongly confident about practices in,place ... the VHA Foundation,today formally launched the "Health Care ...
Cached Medicine News:Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 2Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 3Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 4Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 5Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 6Health News:Location! Location! Location technologies are improving NHS care 2Health News:Scientists identify interacting proteins key to melanoma development, treatment 2Health News:Scientists identify interacting proteins key to melanoma development, treatment 3Health News:VirtualCDO Acts as M&A Advisor in Sale of VasTech to Lawson Software 2Health News:DRAXIS to Report First Quarter Results on May 9th 2Health News:DRAXIS to Report First Quarter Results on May 9th 3Health News:DRAXIS to Report First Quarter Results on May 9th 4Health News:VHA Foundation Launches National CEO Patient SafetyNetwork, Starting From the Top to Make Patients Safer 2Health News:VHA Foundation Launches National CEO Patient SafetyNetwork, Starting From the Top to Make Patients Safer 3
(Date:9/1/2015)... Belgium , Sept. 1, 2015 ... company focused on developing blood-based diagnostic tests for a broad ... its Chief Executive Officer, Cameron Reynolds , is scheduled ... Conference, which is being held September 9-10, 2015 in ... all day on September 10. Wells Fargo ...
(Date:9/1/2015)... BAKERSFIELD, Calif. , Sept. 1, 2015 /PRNewswire/ ... Chronic Care Management (CCM) and Drug Adherence m ... monitoring help automate the process of non face-to-face ... "With this new release of our apps, ... care management services along with our ONCHIT certified ...
(Date:9/1/2015)... , Sept. 1, 2015   Ivenix Inc. ... infusion management system, closed on a $42M round ... Healthcare Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, ... in the round. This financing will support the ... market. Leerink Partners LLC acted as the exclusive ...
Breaking Medicine Technology:VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3
... CHICAGO, June 3, 2011 Cornerstone Pharmaceuticals ... findings from a Phase I clinical trial of Cornerstone,s ... Leukemia (AML). Data will be presented at the 47th ... http://www.chicago2011.asco.org/ . Cornerstone is a leader in the ...
... June 3, 2011 DURECT Corporation (Nasdaq: DRRX ... be presenting at the Jefferies Healthcare Conference on Tuesday, June ... held at the Grand Hyatt in New York.   ... webcast of the presentation will be available by accessing DURECT,s ...
Cached Medicine Technology:Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 2Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 3Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 4
Titanium hemi arthroplasty implant for degenerative and post-traumatic arthritis of first metatarsophalangeal joint....
... Cranial Nerve Electrodes provide direct cranial ... Their patented circumferential design provides sensitive ... high-quality, stable real-time recordings. This unique ... during the removal of acoustic neuromas, ...
... of Ad-Techs products, our Sphenoidal Electrodes are manufactured ... available in stainless steel or platinum and feature ... (70 mm) long, 21 gauge (0.83 mm) introducing ... as kits or sets. You can also choose ...
... Stellate Harmonie workstation is a medical device ... high quality video capability, and archiving demands ... review functions A framework that helps organize ... of data A centralized database and powerful ...
Medicine Products: